Urotensin II and cardiovascular diseases

Peptides

Volumn 25, Issue 10 SPEC. ISS., 2004, Pages 1789-1794

  Thanassoulis, George ^a   Huyhn, Thao ^a   Giaid, Adel ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Atherosclerosis; Coronary artery disease; Heart failure; Metabolic syndrome.; Vascular physiology

Indexed keywords

NEUROPEPTIDE RECEPTOR; SOMATOSTATIN; UNCLASSIFIED DRUG; UROTENSIN II; UROTENSIN II RECEPTOR;

ATHEROSCLEROSIS; BLOOD VESSEL; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CHOLESTEROL METABOLISM; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; ENDOTHELIUM; EX VIVO STUDY; FISH; HUMAN; HYPERTENSION; IN VIVO STUDY; INSULIN RESISTANCE; KIDNEY TUMOR; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PEPTIDE ANALYSIS; PRIMATE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; SMOOTH MUSCLE FIBER; TISSUE DISTRIBUTION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALIA; PRIMATES;

EID: 5144230026     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.05.027     Document Type: Review

References (55)

1. R.S. Ames, H.M. Sarau, J.K. Chambers, R.N. Willette, N.V. Aiyar, and A.M. Romanic Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 Nature 401 1999 282 286
2. D.J. Behm, S.M. Harrison, Z. Ao, K. Maniscalco, S.J. Pickering, and E.V. Grau Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice Br J Pharmacol 139 2003 464 472
3. H.A. Bern, D. Pearson, B.A. Larson, and R.S. Nishioka Neurohormones from fish tails: the caudal neurosecretory system I Rec Prog Horm Res 41 1985 533 552
4. F. Bohm, and J. Pernow Urotensin II evokes potent vasoconstriction in humans in vivo Br J Pharamacol 135 2002 25 27
5. F.E. Bottrill, S.A. Douglas, C.R. Hiley, and R. White Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries Br J Pharmacol 130 2000 1865 1870
6. V. Camarda, A. Rizzi, G. Calo, G. Gendron, S.I. Perron, and E. Kostenis Effects of human urotensin-II in isolated vessels of various species; comparison with other vasoactive agents Naunyn Schmiedebergs Arch Pharmacol 36 2002 141 149
7. J.M. Conlon, K. Yano, D. Waugh, and N. Hazon Distribution and molecular forms of urotensin-II and its role in cardiovascular regulation in vertebrates J Exp Zool 275 1996 226 238
8. J.M. Conlon, H. Tostivint, and H. Vaudry Somatostatin- and urotensin-II related peptides: molecular diversity and evolutionary perspectives Regul Pep 69 1997 95 103
9. Y. Coulouarn, I. Lihrmann, S. Jegou, Y. Anouar, H. Tostivint, and J.C. Beauvillain Cloning of the cDNA encoding urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord Proc Natl Acad Sci 95 1998 15803 15808
10. Y. Coulouarn, S. Jegou, H. Tostivint, Y. Coulouarn, S. Jegou, and H. Tostivint Lihrmann I. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin-II precursors FEBS Lett 457 1999 28 32
11. S.A. Douglas, C.F. Sauermelch, R. Coatney, N.A. Eishourbagy, N.V. Aiyar, and E.H. Ohlstein Characterization of human urotensin-II as the most potent vasoconstrictor identified Circulation 100 Suppl. 1 1999 2993
12. S.A. Douglas, A.C. Sulpizio, V. Piercy, H.M. Sarau, R.S. Ames, and N.V. Aiyar Differential vasoconstrictor activity of the human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey Br J Pharmacol 131 2000 1262 1274
13. S.A. Douglas Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'? Curr Opin Pharmacol 3 2003 159 167
14. S.A. Douglas, L. Tayara, E.H. Ohlstein, N. Halawa, and A. Giaid Congestive heart failure and expression of myocardial urotensin II Lancet 359 2003 1990 1997
15. T. Dschietzig, C. Bartsch, R. Pregla, H.R. Zurbrugg, F.P. Armbruster, and C. Richter Plasma levels and cardiovascular expression of urotensin-II in human heart failure Regul Pep 110 2002 33 38
16. S.M. Gardiner, J.E. March, P.A. Kemp, A.P. Davenport, and T. Bennett Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats Br J Pharmacol 132 2001 1625 1629
17. A. Gibson Complex effects of Gillich-thys urotensin-II on rat aortic strips Br J Pharmacol 91 1987 205 212
18. A. Gibson, S. Conyers, and H.A. Bern The influence of urotensin-II on calcium flux in rat aorta J Pharm Pharmacol 40 1998 893 895
19. A. Gibson, P. Wallace, and H.A. Bern The influence of urotensin-II on calcium influx in rat aorta J Pharm Pharmacol 40 1998 893 895
20. K. Hasegawa, Y. Kobayashi, and H. Kobayashi Vasodepressor effects of urotensin II in rats Neuroendocrinol Lett 14 1992 357 363
21. G.S. Hassan, F. Chouiali, T. Saito, F. Hu, S.A. Douglas, and Z. Ao Effect of human urotensin-II infusion on hemodynamics and cardiac function Can J Physiol Pharmacol 81 2003 125 128
22. J. Heller, M. Schepke, M. Neef, R. Woitas, C. Rabe, and T. Sauerbruch Increase urotensin-II plasma levels in patients with cirrhosis and portal hypertension J Hepatol 37 2002 767 772
23. C. Hillier, C. Berry, M.C. Petrie, P.J. O'Dwyer, C. Hamilton, and A. Brown Effects of urotensin-II in human arteries and veins of varying caliber Circulation 103 2001 1378 1381
24. 2+ Br J Pharmacol 104 1991 847 852
25. H. Itoh, D. McMaster, and K. Lederis Functional receptors for fish neuropeptide urotensin-II in majot rat arteries Eur J Pharmacol 149 1998 61 66
26. C.J. Kelsall, and R.J. Balment Native urotensins influence cortisol secretion and plasma cortisol concentrations in the euryhaline flounder, Platichthys flesus Gen Comp Endocrinol 112 1998 210 219
27. S. Leslie, M. Denvir, and D.J. Webb Human urotensin-II causes vasoconstriction in the human skin microcirculation Circulation 102 Suppl. 2000 542
28. J.J. Maguire, R.E. Kuc, and A.P. Davenport Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1 Br J Phramacol 131 2000 441 446
29. M. Matsushita, M. Shichiri, T. Imai, M. Iwashina, H. Tanaka, and N. Takasu Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues J Hypertens 19 2001 2185 2190
30. A. Marchese, M. Heiber, T. Nguyen, H.H. Heng, V.R. Saldivia, and R. Cheng Cloning and chromosomal mapping of three novel genes, GPR9 GPR10 and GPR 14 encoding receptors related to interleukin-8, neuropeptide Y and somatostatin receptors Genomics 29 1995 335 344
31. L.L. Ng, I. Loke, R.J. O'Brien, I.B. Squire, and J.E. Davies Plasma urotensin in human systolic heart failure Circulation 106 2002 2877 2880
32. H.P. Nothacker, Z. Wang, A.M. McNeill, Y. Saito, S. Merten, and B. O'Dowd Identification of the natural ligand of an orphan G-protein coupled receptor involved in the regulation of vasoconstriction Nat Cell Biol 1 1999 383 385
33. J. Paysant, A. Rupin, S. Simonet, J.N. Fabiani, and T.J. Verbeuren Comparison of the contractile responses of human coronary bypass grafts and monkey arteries to human urotensin-II Fundam Clin Pharmacol 15 2001 227 231
34. D. Pearson, J.E. Shively, B.R. Clark, I.I. Geschwind, M. Barkley, and R.S. Nishioka Urotensin II: somatostatin like peptide in the caudal neurosecretory system of fishes Proc Natl Acad Sci USA 77 1980 5021 5024
35. A.M. Richards, M.G. Nicholls, J.G. Lainchbury, S. Fisher, and T.G. Yandle Plasma urotensin II in heart failure Lancet 360 2002 545 546
36. R.J. Rivas, R.S. Nishioka, and H.A. Bern In vitro effects of somatostatin and urotensin II on prolactin and growth hormone secretion in tilapia Oreochromis mossambicus Gen Comp Endocrinol 63 1986 245 251
37. F.D. Russell, D. Meyers, A.J. Galbraith, N. Bett, I. Toth, and P. Kearns Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure Am J Physiol Heart Circ Physiol 285 2003 1576 1581
38. W.J. Rossowski, B.L. Cheng, J.E. Taylor, R. Datta, and D.H. Coy Human urotensin-II induced aorta ring contractions are mediated by protein kinase C, tyrosine kinase and Rho-kinase: inhibition by somatostatin receptor antagonists Eur J Pharmacol 438 2002 159 170
39. V. Sauzeau, E. Le Mellionec, J. Bertoglio, E. Scalbert, P. Pacaud, and G. Loirand Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase Circ Res 88 2001 1102 1104
40. A. Shenouda, S.A. Douglas, E.H. Ohlstein, and A. Giaid Localization of urotensin-II immunoreactivity in normal human kidneys and renal carcinoma J Histochem Cytochem 50 2002 885 889
41. M.A. Sheridan, and H.A. Bern Both somatostatin and the caudal neuropeptide, urotensin II, stimulate lipid mobilization from coho salmon liver incubated in vitro Regul Pep 14 1986 333 344
42. R.A. Silvestre, J. Rodriguez-Gallardo, E.M. Egido, and J. Marco Inhibition of insulin release by urotensin II - a study on the perfused rat pancreas Horm Metab Res 33 2001 379 381
43. A. Stirrat, M. Gallagher, S.A. Douglas, E.H. Ohlstein, C. Berry, and A. Kirk Potent vasodilator responses to human urotensin-II in human pulmonary resistance arteries: comparison with adrenomedullin and other vasodilators in pulmonary arteries Am J Physiol 280 2001 H925 H928
44. K. Takahashi, K. Totsune, O. Murakami, and S. Shibahara Expression of urotensin II and urotensin II receptor mRNAs in various human tumor cell lines and secretion of urotensin II-like immunoreactivity by SW-13 adrenocortical carcinoma cells Peptides 22 2001 1175 1179
45. M. Tal, D.A. Ammar, M. Karpuj, V. Krizhanovsky, M. Naim, and D.A. Thompson A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia Biochem Biophys Res Commun 209 1995 752 759
46. K. Tamura, M. Okazaki, M. Tamura, K. Isozumi, H. Tasaki, and Y. Nakashima Urotensin-II-induced activation of extracellular signal-regulated kinase in cultured vascular smooth muscle cells: involvement of cell adhesion-mediated integrin signaling Life Sci 72 2003 1049 1060
47. K. Totsune, K. Takahashi, Z. Arihara, M. Sone, F. Satoh, and S. Ito Role of urotensin-II in patients on dialysis Lancet 358 2001 810 811
48. K. Totsune, K. Takahashi, Z. Arihara, M. Sone, S. Ito, and O. Murakami Increased plasma urotensin II levels in patients with diabetes mellitus Clin Sci 104 2003 1 5
49. A. Tzanidis, R.D. Hannan, W.G. Thomas, D. Onan, D.J. Autelitano, and F. See Direct actions of urotensin-II on the heart Implications for cardiac fibrosis and hypertrophy Circ Res 93 2003 246 253
50. T. Watanabe, R. Pakala, T. Katagiri, and C.R. Benedict Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells Circulation 104 2001 16 18
51. A.M. Watson, G.W. Lambert, K.J. Smith, and C.N. May Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions Hypertension 42 2003 373 379
52. Z. Wenyi, S. Suzuki, M. Hirai, Y. Hinokio, Y. Tanizawa, and A. Matsutani Role of urotensin II in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects Diabetologia 46 2003 972 976
53. I.B. Wilkinson, J.T. Affolter, S.L. de Haas, M.P. Pellegrini, J. Boyd, and M.J. Winter High plasma concentrations of human urotensin-II do not alter local or systemic hemodynamics in man Cardiovasc Res 53 2002 341 347
54. P. Ziltener, C. Mueller, B. Haenig, M.W. Scherz, and O. Nayler Urotensin II mediates ERK1/2 phosphorylation and proliferation in GPR14-transfected cell lines J Recept Signal Transduct Res 22 2002 68 155
55. Y. Zou, R. Nagai, and T. Yamazaki Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats FEBS Lett 508 2001 57 60